• Recruiting

NCT05338047: Phase 2: Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery ASCT

NCT05338047: Phase 2: Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant

pegfilgrastim

This is a phase 2 clinical trial comparing time to neutrophil recovery after autotrasplant using generic pegfilgrastim vs brand-name pegfilgrastim.


Sponsor

Hospital Universitario Dr. Jose E. Gonzalez


Information provided by (Responsible Party)

Cesar Homero Gutierrez-Aguirre, Hospital Universitario Dr. Jose E. Gonzalez

 

ClinicalTrials.gov Identifier: NCT05338047


Official Title: Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilgrastim for Neutrophil Recovery After Autologous Stem Cell Transplant


First Posted: April 20, 2022


Click here to see details on ClinicalTrials.gov

 

Pegfilgrastim : National Cancer Institute

 

Drug: Pegfilgrastim

 

Location

Mexico

Hospital Universitario Dr. José Eleuterio González

Monterrey, Nuevo León, Mexico, 66260



Posts Archive